We know from international data that migraine and medication overuse headache (MOH) are extremely prevalent diseases and leading causes of disability worldwide. However, we lack robust, Australian-specific data. We propose a mail out survey-based pilot study across urban and regional areas in Victoria and New South Wales to capture a crucial snapshot of migraine and MOH in Australia. This pilot study will inform us of the magnitude, impact, and current gaps in the treatment paradigm of these conditions. These findings will also inform the development of the first Australia-wide, comprehensive study of headache epidemiology. These data will go towards closing the largest knowledge gap in Australian headache medicine. This research is critical for informing guidelines regarding diagnosis, directing future healthcare priorities, incentivising investment in new therapies, improving equitable access to existing and new treatments, and shaping healthcare pathways that will bring impactful change to individuals’ quality of life, their families, and our communities. This study is endorsed by the Australian and New Zealand Headache Society.
|Effective start/end date||1/01/22 → 30/12/22|